Effects of chinese herbal medicine Feiyanning Decoction on the ratio of CD4+ CD25+ regulatory T cells and expression of transcription factor foxp3 in mice bearing lewis lung carcinoma

Journal of Chinese Integrative Medicine

Volumn 10, Issue 5, 2012, Pages 584-590

  Guo, Jing ^a   Wang, Ju Yong ^a   Zheng, Zhan ^a   Wang, Qing ^a   Dong, Chang Sheng ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Chinese herbal; Drugs; Foxp3; Lewis lung cancer; Mice; Regulatory T cells

Indexed keywords

ANTINEOPLASTIC AGENT; FEIYANNING DECOCTION; MESSENGER RNA; PLANT MEDICINAL PRODUCT; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL FOOD; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CANCER COMBINATION CHEMOTHERAPY; CANCER SIZE; CD4+ CD25+ T LYMPHOCYTE; CHINESE MEDICINE; CONTROLLED STUDY; DRUG EFFECT; FLOW CYTOMETRY; FOOD INTAKE; HERBAL MEDICINE; LEWIS CARCINOMA; LYMPHOCYTE COUNT; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR DOWN REGULATION;

ANIMALS; CARCINOMA, LEWIS LUNG; DRUGS, CHINESE HERBAL; FORKHEAD TRANSCRIPTION FACTORS; MALE; MICE; MICE, INBRED C57BL; T-LYMPHOCYTES, REGULATORY;

EID: 84861618105     PISSN: 16721977     EISSN: None     Source Type: Journal    
DOI: 10.3736/jcim20120515     Document Type: Article

References (14)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011; 61(2): 69-90
2. Mackinnon AC, Kopatz J, Sethi T. The molecular and cellular biology of lung cancer: identifying novel therapeutic strategies. Br Med Bull. 2010; 95: 47-61.
3. + regulatory T cells to extracellular metabolites nicotinamide adenine dinucleotide and ATP: a role for P2X7 receptors. J Immunol. 2005; 175 (5): 3075-3083.
4. + CD25+ regulatory T cells in the peripheral blood of advanced stage lung cancer patients. Med Oncol. 2010; 27(1): 29-33.
5. + regulatory T cell in patients with lung cancer. Zhongguo Shi Yong Yi Kan. 2009; 36(8): 3-5. Chinese with abstract in English. 2009; 36(8): 3-5.
6. + regulatory T-cells are associated with recurrence in pathologic stage I NSCLC patients. Cancer. 2006; 107(12): 2866-2872.
7. + regulatory T cells are correlated with cyclooxygenase-2 expression and are associated with recurrence in resected non-small cell lung cancer. J Thorac Oncol. 2010; 5(5): 585-590.
8. + regulatory T cells in K-Ras-driven lung tumorigenesis. PLoS One. 2009; 4 (3): e5061.
9. + regulatory T cells decreased the antitumor activity of cytokine-induced killer (CIK) cells of lung cancer patients. J Clin Immunol. 2007; 27 (3): 317-326.
10. + T regulatory cell activities in lung cancer. Cancer Res. 2005; 65(12): 5211-5220.
11. + Treg in mice with Lewis lung cancer and the clinical significance. Xian Dai Zhong Liu Yi Xue. 2007; 15(4): 454-457.
12. Xu ZY, Jin CJ, Zhou CC, Wang ZQ, Zhou WD, Deng HB, Zhang M, Su W, Cai XY. Treatment of advanced non-small-cell lung cancer with Chinese herbal medicine by stages combined with chemotherapy. J Cancer Res Clin Oncol. 2011; 137(7): 1117-1122.
13. Wang JY, Zheng Z, Wang Q, Guo J, Chen L. Antitumor mechanism preliminary studied by proteome on Feiyanning Granule against lung cancer in nude mice. Zhong Liu Fang Zhi Yan Jiu. 2011; 38(1): 5-8.
14. Wang JY, Jin Y, Xu ZY, Zheng Z. Effects of Feiyanning Decoction on gene expression of nuclear factor-κB activated by tumor necrosis factor-α in lung adenocarcinoma cell line. J Chin Integr Med. 2009; 7(3): 249-254.